Why Novartis Should Launch Afinitor In China

Core View: The prevalence of chronic diseases will increase dramatically in emerging markets. As economies in these countries develop, incomes rise and people consume more calories, leading to conditions such as obesity and diabetes. Urbanisation is also a fundamental trend in emerging countries, leading to more sedentary lifestyles and exacerbating the burden of chronic

To read the full article, please choose one of the following options: